Weight-loss drugs linked to these deficiencies reported by users, research reveals

Key Points:

• Research indicates that GLP-1 medication users, numbering around 30 million Americans, are experiencing deficiencies in key nutrients such as vitamin B12, protein, and fiber, which are essential for nerve protection, muscle repair, and digestive health.
• A significant portion of GLP-1 users, including 43% with inadequate protein intake, face digestive issues like nausea and constipation due to low fiber consumption, potentially exacerbating poor nutrition.
• Children and adolescents using GLP-1 drugs for obesity are also at risk, with nearly one in six diagnosed with nutrient deficiencies, particularly vitamin D, which is crucial for bone and immune health during development.
• Middle-aged and older adults show concerning rates of vitamin D deficiency after prolonged GLP-1 use, raising risks for bone deterioration and related health complications.
• Experts emphasize the urgent need to integrate nutritional monitoring and support into GLP-1 treatment plans to prevent adverse health effects such as fatigue, hair loss, and weakened immunity linked to these deficiencies.